Top Markets
#1 EXOD EXOD +22.08%
#2 Ontology Gas Ontology Gas +19.69%
#3 Status Status +14.56%
#4 Fake World Assets Fake World Assets +11.65%
#5 Derive Derive +10.56%
#6 aelf aelf +10.13%
#7 Gas Gas +6.52%
#8 ETHGas ETHGas +6.08%
#9 Anvil Anvil +5.80%
#10 Tornado Cash Tornado Cash +5.60%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Mendus AB (publ) Mendus AB (publ)

Mendus AB (publ)

IMMU
株式のランク #25837
Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB... Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB (publ) until its name change in June 2022, specializes in developing immunotherapies and vaccines designed to prevent cancer recurrence. Its primary investigational compound, ilixadencel, is currently progressing through a Phase II MERECA clinical study for kidney cancer, alongside Phase I/II trials targeting liver cancer and gastrointestinal stromal tumors. Additionally, the company is advancing DCP-001, which is undergoing Phase II ADVANCE-II clinical research for acute myeloid leukemia and Phase I/II ALISON trials for ovarian cancers. Mendus maintains research partnerships with PCI Biotech Holding ASA to explore novel cancer vaccination approaches and with the Icahn School of Medicine at Mount Sinai. Founded in 2002, Mendus AB is headquartered in Stockholm, Sweden.
株価
$0.74834668
最終同期: 2026-08-20
時価総額
$45.86M
変化（1日）
-0.15%
変化（1年）
-2.71%
国
SE
取引 Mendus AB (publ) (IMMU)

カテゴリー

Healthcare
Mendus AB (publ)（IMMU）の株価履歴
終値の最高値: $0.75 （2026-08-01）

終値の最安値: $1.01 （2013-04-01）
Mendus AB (publ) の株価履歴（2013 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) 14.30%
2025 -29.72%
2024 -32.55%
2023 -76.95%
2022 -39.21%
2021 -55.05%
2020 -17.38%
2019 29.23%
2018 -11.66%
2017 -59.00%
2016 -42.62%
2015 63.38%
2014 -42.62%
2013 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.71 -17.54%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US